Cite
HARVARD Citation
Liu, K. et al. (n.d.). IDDF2020-ABS-0166 Novel mirna-based drug CD5–2 reduces liver tumour growth in diethylnitrosamine (DEN)-treated mice by normalising tumour vasculature and altering immune infiltrate. Gut. pp. A2-A3. [Online].